Travis J. Carlson
Travis J. Carlson
The University of Texas at Austin College of Pharmacy
Verified email at
Cited by
Cited by
Real-world multicenter analysis of clinical outcomes and safety of meropenem-vaborbactam in patients treated for serious gram-negative bacterial infections
S Alosaimy, SCJ Jorgensen, AM Lagnf, S Melvin, RP Mynatt, TJ Carlson, ...
Open Forum Infectious Diseases 7 (3), ofaa051, 2020
Real-world, multicenter experience with meropenem-vaborbactam for gram-negative bacterial infections including carbapenem-resistant Enterobacterales and Pseudomonas aeruginosa
S Alosaimy, AM Lagnf, T Morrisette, MR Scipione, JJ Zhao, ...
Open forum infectious diseases 8 (8), ofab371, 2021
Clostridioides difficile ribotype 106: A systematic review of the antimicrobial susceptibility, genetics, and clinical outcomes of this common worldwide strain
TJ Carlson, D Blasingame, AJ Gonzales-Luna, F Alnezary, KW Garey
Anaerobe 62, 102142, 2020
Reduced Susceptibility to Metronidazole Is Associated With Initial Clinical Failure in Clostridioides difficile Infection
AJ Gonzales-Luna, AO Olaitan, WJ Shen, A Deshpande, TJ Carlson, ...
Open forum infectious diseases 8 (8), ofab365, 2021
PCR ribotypes of Clostridioides difficile across Texas from 2011 to 2018 including emergence of ribotype 255
AJ Gonzales-Luna, TJ Carlson, KM Dotson, K Poblete, G Costa, ...
Emerging Microbes & Infections 9 (1), 341-347, 2020
Early multicenter experience with imipenem-cilastatin-relebactam for multidrug-resistant gram-negative infections
N Rebold, T Morrisette, AM Lagnf, S Alosaimy, D Holger, K Barber, ...
Open Forum Infectious Diseases 8 (12), ofab554, 2021
Eosinopenia and Binary Toxin Increase Mortality in Hospitalized Patients With Clostridioides difficile Infection
TJ Carlson, BT Endres, J Le Pham, AJ Gonzales-Luna, FS Alnezary, ...
Open forum infectious diseases 7 (1), ofz552, 2020
Ridinilazole for the treatment of Clostridioides difficile infection
TJ Carlson, BT Endres, E Bassères, AJ Gonzales-Luna, KW Garey
Expert opinion on investigational drugs 28 (4), 303-310, 2019
Emerging Options for the Prevention and Management of Clostridioides difficile Infection
AJ Gonzales-Luna, TJ Carlson, KW Garey
Drugs 83 (2), 105-116, 2023
Gut microbiota changes associated with Clostridioides difficile infection and its various treatment strategies
AJ Gonzales-Luna, TJ Carlson, KW Garey
Gut Microbes 15 (1), 2223345, 2023
In Vitro Activity of Omadacycline, a New Tetracycline Analog, and Comparators against Clostridioides difficile
K Begum, E Bassères, J Miranda, C Lancaster, AJ Gonzales-Luna, ...
Antimicrobial Agents and Chemotherapy 64 (8), 10.1128/aac. 00522-20, 2020
Antibiotic Treatment Pipeline for Clostridioides difficile Infection (CDI): A Wide Array of Narrow-Spectrum Agents
TJ Carlson, AJ Gonzales-Luna
Current Infectious Disease Reports 22, 1-11, 2020
National disparities in antibiotic prescribing by race, ethnicity, age group, and sex in United States ambulatory care visits, 2009 to 2016
EH Young, KA Strey, GC Lee, TJ Carlson, JM Koeller, VM Mendoza, ...
Antibiotics 12 (1), 51, 2022
Fulminant Clostridioides difficile infection: a review of treatment options for a life-threatening infection
TJ Carlson, AJ Gonzales-Luna, KW Garey
Seminars in Respiratory and Critical Care Medicine 43 (01), 028-038, 2022
Challenges in drug discovery for intracellular bacteria
AN Tucker, TJ Carlson, A Sarkar
Pathogens 10 (9), 1172, 2021
In vitro activity of eravacycline against common ribotypes of Clostridioides difficile
E Basseres, K Begum, C Lancaster, AJ Gonzales-Luna, TJ Carlson, ...
Journal of Antimicrobial Chemotherapy 75 (10), 2879-2884, 2020
Significant publications on infectious diseases pharmacotherapy in 2018
J Borjan, AJ Gonzales-Luna, TJ Carlson, NA Finch, AP Mitchell, ...
Journal of Pharmacy Practice 32 (5), 546-557, 2019
Clostridioides difficile Infection Treatment and Outcome Disparities in a National Sample of United States Hospitals
EH Young, KA Strey, GC Lee, TJ Carlson, JM Koeller, KR Reveles
Antibiotics 11 (9), 1203, 2022
Corticosteroids Do Not Increase the Likelihood of Primary Clostridioides difficile Infection in the Setting of Broad-Spectrum Antibiotic Use
TJ Carlson, AJ Gonzales-Luna, MF Wilcox, SG Theriault, FS Alnezary, ...
Open Forum Infectious Diseases 8 (10), ofab419, 2021
Assessment of Kidney Injury as a Severity Criteria for Clostridioides Difficile Infection
TJ Carlson, AJ Gonzales-Luna, K Nebo, HY Chan, NLT Tran, S Antony, ...
Open Forum Infectious Diseases 7 (11), ofaa476, 2020
The system can't perform the operation now. Try again later.
Articles 1–20